Stifel raises Hinge Health stock price target on app growth rebound

Stifel has raised its price target for Hinge Health stock, citing a rebound in the company's app growth. This change was reported on October 25, 2026.

According to Investing.com, Stifel's new price target reflects the company's improved outlook. Similar reports were also published on Investing.com España, which noted that Stifel elevated its price target for Hinge Health due to the app's growth rebound.

The exact details of the new price target have not been specified in the reports from Investing.com and Investing.com España. The same sources also mentioned that Stifel raised the price target for ORIC Pharmaceuticals to $18 on ESMO data.

What the future holds for Hinge Health and how the market will respond to Stifel's revised price target remains to be seen. Further information or updates on this story have not been reported yet.